A pharma R&D chief jumps to a budding new startup factory — and this time he’s found 'something completely different’
Over the course of a tumultuous year, Paul Biondi has been quietly building a new operation inside Flagship Pioneering, one of the most ambitious biotech builders in the VC world. Looking to draw together new drug programs out of the Flagship armada, the Bristol Myers BD vet is setting up a slate of single-asset companies built around new therapeutics that can be spun out of the portfolio of platform companies they specialize in.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.